207 13F filers hold it · +36 against the quarter before · shares held +0.6%
Holdings of 06/30
StocksIs Wall Street adding or cutting?+36 Is stock about to come to market?$2.9M
All insider trades in Amylyx Pharmaceuticals
All planned sales of Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Health care sectorNasdaq
What to see in Amylyx Pharmaceuticals now
$2.9M of planned sales filed in 30 days · 14.9% of the units outstanding
Filed 09/11
Company
- Exchange
- Nasdaq
- Sector
- Health care
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, Massachusetts
- Fiscal year end
- 12/31
- Next earnings
- 11/05, estimated
- $2.9M of planned sales filed in 30 days · 14.9% of the units outstandingFiled 09/11
Insider trades
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Karen FirestoneDirector | Open-market buy | 05/21 | 05/26 | 3,800 sh | $13.51 | $51,338 | +6.0% |
James M. FratesChief Financial Officer | Open-market sale | 03/02 | 03/04 | 7,909 sh | $14.52 | $114,838.68 | −4.6% |
Camille L. BedrosianChief Medical Officer | Open-market sale | 03/02 | 03/04 | 6,461 sh | $14.58 | $94,201.38 | −3.7% |
Joshua B. CohenCo-Chief Executive Officer | Open-market sale | 03/02 | 03/04 | 29,282 sh | $14.48 | $424,003.36 | −0.9% |
Gina MazzarielloChief Legal Officer | Open-market sale | 03/02 | 03/04 | 6,844 sh | $14.52 | $99,374.88 | −4.8% |
Planned sales
Camille L. BedrosianOfficer | Amylyx PharmaceuticalsAMLX | 10,028 sh | $324,868 | 09/10 | Filed 09/11 |
James M. FratesOfficer | Amylyx PharmaceuticalsAMLX | 10,810 sh | $349,821 | 09/10 | Filed 09/11 |
Justin B. KleeOfficer, Director | Amylyx PharmaceuticalsAMLX | 30,464 sh | $980,264 | 09/10 | Filed 09/11 |
Joshua B. CohenOfficer, Director | Amylyx PharmaceuticalsAMLX | 30,464 sh | $980,504 | 09/10 | Filed 09/11 |
Gina MazzarielloOfficer | Amylyx PharmaceuticalsAMLX | 9,536 sh | $309,506 | 09/10 | Filed 09/11 |
Gina MazzarielloOfficer | Amylyx PharmaceuticalsAMLX10b5-1 plan | 30,000 sh | $536,400 | 07/09 | Filed 07/09 |
James M. FratesOfficer | Amylyx PharmaceuticalsAMLX | 7,909 sh | $114,852 | 03/02 | Filed 03/02 |
Camille L. BedrosianOfficer | Amylyx PharmaceuticalsAMLX | 6,461 sh | $94,205 | 03/02 | Filed 03/02 |
Justin B. KleeOfficer, Director | Amylyx PharmaceuticalsAMLX | 29,282 sh | $423,760 | 03/02 | Filed 03/02 |
Joshua B. CohenOfficer, Director | Amylyx PharmaceuticalsAMLX | 29,282 sh | $424,120 | 03/02 | Filed 03/02 |